cardiovascular

Terje Pedersen Terje Pedersen, Ulleval University, Oslo Eugene Braunwald, Harvard University, Boston Lowering LDL Cholesterol intensively as a means of treating aortic stenosis was found to have no be

Nigel Beckett Nick Boon Nigel Beckett, Imperial College, London COMMENT: Nick Boon, British Cardiovascular Society, London Even very old patients benefit greatly if you treat their hypertension. This

Colin Baigent REFERENCE: Lancet 371:117 January 11, 2008 COLIN BAIGENT, Oxford University Statins were found to cut cardiovascular event rates by a fifth among patients with both Type I and Type II di

George Sopko

Ernst Rietzschel Jennifer Mieres REFERENCE: News Briefing, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida N Engl J Med 2007;357 ERNST RIETZSCHEL, University of Gh

Gregg Stone REFERENCE: Abstract 2357, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida GREGG STONE, Columbia University, New York New light has been thrown on the u

Philip Barter Gordon Tomaselli REFERENCE: Late Breaking Clinical Trials, Session 2, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida N Engl J Med 2007;357 PHILIP BA

Ake Hjalmarson Gordon Tomaselli REFERENCE: Late Breaking Clinical Trials, Session 2, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida N Engl J Med 2007;357 AKE HJAL

Uwe Zeymer REFERENCE: Late Breaking Clinical Trials Session I, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida UWE ZEYMER, Herzzentrum Ludwigshafen, Germany The gl

Gordon Tomaselli Daniel Jones REFERENCE: Late Breaking Clinical Trials 1, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida GORDON TOMASELLI, Johns Hopkins Universit

Laura Mauri Raymond Gibbons REFERENCE: Late Breaking Special Session, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida LAURA MAURI, Brigham and Woman’s Hospit

REFERENCE: Abstract: Late Breaking Clinical Trials, Session 1, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida LESLEE SHAW, Emory University, Atlanta COMMENT: DANI

Edmond Cronin REFERENCE: Abstract 3506, European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria EDMOND CRONIN, Cork University Hospital Study data that support banning smoking in

Curt Diehm REFERENCE: European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria CURT DIEHM, University of Heidelberg Peripheral arterial disease (PAD) can be diagnosed easily by a

Stuart Pocock REFERENCE: ABSTRACT N Engl J Med 2007; 357: 28-381 STUART POCOCK, London School of Hygiene and Tropical Medicine Reassuring findings about the safety of the anti-diabetic drug rosiglitaz

HARVEY WHITE, Auckland City Hospital, New Zealand REFERENCE: ACUITY Trial, ACC.07 Scientific Session and i2 Innovations Summit. Presentation Number: 2414-5 Patients with acute coronary syndromes who t

JAIME MIRANDA, London School of Hygiene and Tropical Medicine, Peru The consequences of migration from rural to urban areas in Peru has provided an opportunity for studying the impact of a radically a

HARVEY WHITE, Auckland City Hospital REFERENCE: ACC 2007 & N Engl J Med 356: March 2007 The finding from the COURAGE trial: that angioplasty adds no benefits to optimal medical therapy alone for

Jeffrey Anderson Douglas Zipes JEFFREY ANDERSON, University of Utah, Salt Lake City COMMENT: DOUGLAS ZIPES, University of Indiana, Indianapolis REFERENCE: Abstract 1020-89, American College of Cardiol

DAVID MOLITERNO, University of Kentucky, Lexington REFERENCE: American College of Cardiolgy New Orleans, March 24th Late Breaking Trials An oral thrombin receptor antagonist, SCH 530348 has proved saf